NO881501L - Rekombinante htlv-111-proteiner og anvendelser av disse. - Google Patents

Rekombinante htlv-111-proteiner og anvendelser av disse.

Info

Publication number
NO881501L
NO881501L NO88881501A NO881501A NO881501L NO 881501 L NO881501 L NO 881501L NO 88881501 A NO88881501 A NO 88881501A NO 881501 A NO881501 A NO 881501A NO 881501 L NO881501 L NO 881501L
Authority
NO
Norway
Prior art keywords
proteins
protein
htlv
fusion protein
fusion
Prior art date
Application number
NO88881501A
Other languages
English (en)
Other versions
NO881501D0 (no
Inventor
Debra Lynn
Kashayar Javaberian
William Thomas Mueller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of NO881501D0 publication Critical patent/NO881501D0/no
Publication of NO881501L publication Critical patent/NO881501L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nye, rekoobinante HTLV-III-sammensmeltningsproteiner benevnt RIO, PB1, 590, KH1, og HIV-delen av hvert av disse proteiner er anvendelige i diagnosen, profylaksen eller terapien av AIDS. Protein RIO er et 95 kO sammensmeltningsprotein; protein1 er et 26 IcO sammensmeltningsprotein; protein 590 er et 86 kD sammensmelt-ningsproteini og protein KH1 er et 70 kO saimnensmeltningsprotein. Disse proteiner betraktes å være spesielt anvendelige for å fremstille vaksiner mot HTLV-III-viruset.
NO88881501A 1987-10-09 1988-04-07 Rekombinante htlv-111-proteiner og anvendelser av disse. NO881501L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10723187A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
NO881501D0 NO881501D0 (no) 1988-04-07
NO881501L true NO881501L (no) 1989-04-10

Family

ID=22315557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88881501A NO881501L (no) 1987-10-09 1988-04-07 Rekombinante htlv-111-proteiner og anvendelser av disse.

Country Status (6)

Country Link
JP (1) JPH01193228A (no)
KR (1) KR890006250A (no)
AU (1) AU613944B2 (no)
NO (1) NO881501L (no)
PT (1) PT87208A (no)
ZA (1) ZA883261B (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861626A7 (fi) * 1985-04-19 1986-10-20 Hoffmann La Roche Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus

Also Published As

Publication number Publication date
AU2117288A (en) 1989-04-13
ZA883261B (en) 1988-12-06
KR890006250A (ko) 1989-06-12
JPH01193228A (ja) 1989-08-03
PT87208A (pt) 1989-07-31
NO881501D0 (no) 1988-04-07
AU613944B2 (en) 1991-08-15

Similar Documents

Publication Publication Date Title
DE69333802D1 (de) Äusseres membranprotein von haemophilus
DE3786592D1 (de) Transformation von trichoderma.
DK371087A (da) Mamalialt interleukin-4
ATE57836T1 (de) Nichtdenaturierte virusfreie biologisch aktive proteinderivate.
DE3382837D1 (de) Herstellung von funktionellen, menschlichen Urokinaseproteinen
ES2108681T3 (es) Expresion de la albumina del suero humano en las levaduras metilotroficas.
DE68923123D1 (de) Herstellung von Proteinen.
BG44537A3 (en) Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate
EP0255190A3 (en) Recombinant polypeptides and their uses, inclusing assay for aids virus
FI88931B (fi) Nya enzymer foer uppspjaelkning av lignin
NO883834L (no) Nye hiv-proteiner og peptider anvendelige i diagnosen, profylaksen eller terapien av aids.
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
DE58908428D1 (de) Sekretormutante von Escherichia coli.
FI885296L (fi) Rekombinant hiv-2 polypeptid.
FI93843C (fi) Menetelmä angiogeenisen tekijän tuottamiseksi
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
ES2101694T3 (es) Expresion de edulcorantes proteinicos en levadura.
WO1989009227A3 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
EP0281978A3 (en) Inactivation of human immunodeficiency virus (hiv) in proteinic solutions by means of phenol
DK708488D0 (da) Faktor i praeparat
ES2059323T3 (es) Procedimiento para la produccion de una preparacion de inmunoglobulina pasteurizada.
ATE119166T1 (de) An hiv relatierte peptide.
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.